The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Chronic Hydroxychloroquine Use Associated with QT Prolongation and Refractory Ventricular Arrhythmia
Abstract
BACKGROUND: Hydroxychloroquine (HCQ) is used for treatment of lupus erythematosus. The cardiac toxicity of HCQ has focused primarily on acute intoxication. We report a case of chronic use of HCQ associated with torsade de pointes. CASE REPORT: A 67-year-old female presented with acquired long QT interval syndrome with a refractory ventricular arrhythmia. She was receiving chronic therapeutic doses of HCQ for the treatment of lupus erythematosus. Torsades de pointes was diagnosed in the Emergency Department (ED). After excluding other causes of long QT syndrome, the HCQ was suspected as the cause of her ventricular tachycardia. After discontinuing the HCQ, the QT interval was shorter and the patient recovered after treatment with lidocaine and isoproterenol. CONCLUSION: The chronic use of HCQ for rheumatic diseases, or as an anti-malarial drug, should be balanced against the risk of developing potentially lethal cardiac arrhythmias.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases
Furst, D. E. (1996) · Lupus · doi:10.1177/0961203396005001041 · Cited by 233
Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients
Curtis, L. H., Østbye, T., Sendersky, V., Hutchison, S., Allen LaPointe, N. M., Al-Khatib, S. M., Usdin Yasuda, S., Dans, P. E., Wright, A., Califf, R. M., et al. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01455-9 · Cited by 176
Risk of torsades de pointes with non-cardiac drugs
Yap, Y. G. (2000) · BMJ · doi:10.1136/bmj.320.7243.1158 · Cited by 155
Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients
Curtis, L. H., Østbye, T., & Sendersky, V. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(03)00200-9 · Cited by 149
Fong, K., & Feng, P.-H. (1996) · Lupus · doi:10.1177/096120339600500104 · Cited by 66
Cited by
Impact of sex and gender on COVID-19 outcomes in Europe
Gebhard, C., Regitz-Zagrosek, V., Neuhauser, H. K., Morgan, R., & Klein, S. L. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00304-9 · Cited by 1,306
Bhimraj, A., Morgan, R. L., Shumaker, A. H., Lavergne, V., Baden, L., Cheng, V. C.-C., Edwards, K. M., Gandhi, R., Muller, W. J., O’Horo, J. C., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa478 · Cited by 1,033
Ruiz-Irastorza, G., Ramos-Casals, M., Brito-Zeron, P., & Khamashta, M. A. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.101766 · Cited by 978
Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment
Roden, D. M., Harrington, R. A., Poppas, A., & Russo, A. M. (2020) · Circulation · doi:10.1161/circulationaha.120.047521 · Cited by 779
Elens, L., Langman, L. J., Hesselink, D. A., Bergan, S., Moes, D. J. A. R., Molinaro, M., Venkataramanan, R., & Lemaitre, F. (2020) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000761 · Cited by 677
Metadata
- Authors
- Chen, C.-Y., Wang, F.-L., & Lin, C.-C.
- Venue
- Clinical Toxicology
- Publisher
- Informa UK Limited
- Published
- 2006-01
- Volume
- 44
- Issue
- 2
- Pages
- 173-175
- ISSN
- 0009-9309 (ISSN-L)
- 1556-3650
- 1556-9519
- OpenAlex
- W2100295295
- Cited by
- 270
- References
- 5
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chronic Hydroxychloroquine Use Associated with QT Prolongation and Refractory Ventricular Arrhythmia. https://app.cochat.ai/papers/10.1080/15563650500514558
- The paper
- Chen, C.-Y., Wang, F.-L., & Lin, C.-C. (2006). Chronic Hydroxychloroquine Use Associated with QT Prolongation and Refractory Ventricular Arrhythmia. Clinical Toxicology. https://doi.org/10.1080/15563650500514558
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.